Weatherall DJ: The thalassaemias: the role of molecular genetics in an evolving global health problem. Am J Hum Genet. 2004, 74: 385-392. 10.1086/381402.
Angastiniotis M, Modell B: Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci. 1998, 850: 251-269. 10.1111/j.1749-6632.1998.tb10482.x.
Wong HB: Prevention of thalassaemias in South-East Asia. Ann Acad Med Singapore. 1985, 14: 654-665.
Diagnosis of Thalassemia Carriers. [http://www.thalassemia.or.th/thaiversion/diag-carrier-th.htm]
De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC: Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006, 19: 471-480.
Mikelli A, Tsiantis J: Brief report: Depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc. 2004, 27: 213-216. 10.1016/j.adolescence.2003.11.011.
Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M: Quality of life in thalassemia. Ann N Y Acad Sci. 2005, 1054: 273-282. 10.1196/annals.1345.035.
Caro JJ, Ward A, Green TC, Huybrechts K, Arana A, Wait S, Eleftheriou A: Impact of thalassemia major on patients and their families. Acta Haematol. 2002, 107: 150-157. 10.1159/000057633.
Cohen A: Management of iron overload in pediatric patients. Hematol Oncol Clin North Am. 1987, 1: 521-544.
Cao A: Quality of life and survival of patients with beta-thalassemia major. Haematologica. 2004, 89: 1157-1159.
Ismail A, Campbell MJ, Ibrahim HM, Jones GL: Health related quality of life in Malaysian children with thalassaemia. Health and Quality of Life Outcomes. 2006, 4: 39-10.1186/1477-7525-4-39.
Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP: Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci. 2005, 1054: 457-461. 10.1196/annals.1345.059.
Shaligram D, Girimaji SC, Chaturvedi SK: Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007, 74: 727-730. 10.1007/s12098-007-0127-6.
Abetz L, Baladi J, Jones P, Rofail D: The impact of iron overload and its treatment on quality of life: results from a literature review. Health and Quality of Life Outcomes. 2006, 4: 73-10.1186/1477-7525-4-73.
Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi F, Piga A, Cnaan A: Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004, 89: 1187-1193.
Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A: Survival in medically treated patients with homozygous beta-thalassemia. New Eng J Med. 1994, 331: 574-578. 10.1056/NEJM199409013310903.
Porter J, Davis BA: Monitoring chelation treatment to achieve optimal outcome in the treatment of thalassemia. Best Pract Res Clin Haematol. 2000, 15: 329-368.
Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S: Survival and causes of death in thalassaemia major. Lancet. 1989, 2: 27-30. 10.1016/S0140-6736(89)90264-X.
Forrest CB, Simpson L, Clancy C: Child health services research: challenges and opportunities. JAMA. 1997, 277: 1787-1793. 10.1001/jama.277.22.1787.
Homer CJ, Kleinman LC, Goldman DA: Improving the quality of care for children in health systems. Health Serv Res. 1998, 33: 1091-1109.
McGlynn EA, Halfon N, Leibowitz A: Assessing the quality of care for children: prospects under health reform. Arch Pediatr Adolesc Med. 1995, 149: 359-368.
Seid M, Varni JW, Segall D, Kurtin PS: Health-related quality of life as a predictor of pediatric healthcare costs: a two-year prospective cohort analysis. Health and Quality of Life Outcomes. 2004, 2: 48-10.1186/1477-7525-2-48.
Lemeshow S, Hosmer DW, Klar J, Lwanga SK: Adequacy of sample size in health studies. 1990, Chichester: John Wiley and Sons
Varni JW, Seid M, Knight TS, Uzark K, Szer IS: The PedsQL 4.0 generic core scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med. 2002, 25: 175-193. 10.1023/A:1014836921812.
Varni JW, Seid M, Kurtin PS: The PedsQL: Measurement model for the Pediatric Quality of Life Inventory. Med Care. 1999, 37: 126-139. 10.1097/00005650-199902000-00003.
Varni JW, Seid M, Kurtin PS: PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001, 39: 800-812. 10.1097/00005650-200108000-00006.
Pongwilairat K, Louthrenoo O, Charnsil C, Witoonchart C: Quality of life of children with attention-deficit/hyperactivity disorder. J Med Assoc Thailand. 2005, 88: 1062-1066.
Telfer PT, Prestcott E, Holden S: Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassemia major. Br J Haematol. 2000, 110: 971-977. 10.1046/j.1365-2141.2000.02298.x.
Dubey AP, Parakh A, Dublish S: Current trends in the management of beta-thalassemia. Indian J Pediatr. 2008, 75: 739-743. 10.1007/s12098-008-0140-4.
Sripichai O, Makarasara W, Munkongdee T, Kumkhaek C, Nuchprayoon I, Chuansumrit A, Chuncharunee S, Chantrakoon N, Boonmongkol P, Winichagoon P, Fucharoen S: A scoring system for the classification of beta-thalassemia/Hb E disease severity. Am J Hematol. 2008, 83: 482-484. 10.1002/ajh.21130.
Anionwu E, Atkin K: The politics of sickle cell and thalassaemia. 2001, Buckingham: Open University Press
Musallam K, Cappellini MD, Taher A: Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthood. Pediatrics. 2008, 121: e1426-1429. 10.1542/peds.2007-1944.
Saeed N: My life. United Kingdom Thalassaemia Society Matters. 2004, 99: 10-
Afsar B, Ozdemir NF, Sezer S, Haberal M: Quality of life is not related with liver disease severity but with anemia, malnutrition and depression in HCV-infected hemodialysis patients. Hemodial Int. 2009, 13: 62-71. 10.1111/j.1542-4758.2009.00329.x.
Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, Soroka S, Mujais S: Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol. 2008, 4: 33-38. 10.2215/CJN.00630208.
Santos PR, Kerr LRFS: Clinical and laboratory variables associated with quality of life in Brazilian haemodialysis patients: a single-centre study. Rev Med Chile. 2008, 136: 1264-1271.
Thein M, Ershler WB, Artz AS, Tecson J, Robinson BE, Rothstein G, Liede A, Gylys-Colwell I, Lu ZJ, Robbins S: Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicare (Baltimore). 2009, 88: 107-114. 10.1097/MD.0b013e31819d89d5.
Cianciulli P: Treatment of iron overload in thalassemia. Pediatr Endocrinol Rev. 2008, 6 (Suppl 1): 208-213.
Marinov BI, Terziyski KV, Sapunarova KG, SS K: Exercise performance in children with severe beta-thalassemia before and after transfusion. Folia Med (Plovdiv). 2008, 50 (4): 48-54.
Wanapirak C, Tongsong T, Sirivatanapa P, Sa-nguansermsri T, Sekararithi R, A T: Prenatal strategies for reducing severe thalassemia in pregnancy. Int J Gynaecol Obstet. 1998, 60 (3): 239-244. 10.1016/S0020-7292(97)00271-3.
Phadke SR, S A: Phenotype score to grade the severity of thalassemia intermedia. Indian J Pediatr. 2003, 70 (6): 477-481. 10.1007/BF02723137.
Osborne RH, De Abreu Lourenço R, Dalton A, Houltram J, Dowton D, Joshua DE, Lindeman R, Ho PJ: Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study. Value in Health. 2007, 10: 451-456. 10.1111/j.1524-4733.2007.00200.x.